A Narrative Review on Thrombolytics in Advanced CKD: Is it an Evidence-Based Therapy?
Alexandru BurlacuBogdan ArteneAdrian CovicPublished in: Cardiovascular drugs and therapy (2019)
The impact of TT on the outcomes of advanced CKD patients is poorly understood to date, with scarce data available in current guidelines and conflicting results from observational studies. Until evidence-based data from RCTs will be obtained, the clinical challenge of maximizing benefits for this high-risk subgroup lays in the hands of practicing clinicians.
Keyphrases
- chronic kidney disease
- end stage renal disease
- electronic health record
- ejection fraction
- newly diagnosed
- prognostic factors
- palliative care
- type diabetes
- stem cells
- clinical trial
- randomized controlled trial
- insulin resistance
- adipose tissue
- skeletal muscle
- cell therapy
- patient reported
- replacement therapy
- smoking cessation